These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1847120)

  • 21. [Hepatitis C virus and transfusion: policy regarding the donation and the donor. Groupe "Hépatites Virales" de la Société Nationale de Transfusion Sanguine].
    Moncharmont P; Janot C; Boudart D; Cotte C; Couroucé AM; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):205-10. PubMed ID: 1329793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia.
    Sugitani M; Inchauspé G; Shindo M; Prince AM
    Lancet; 1992 Apr; 339(8800):1018-9. PubMed ID: 1349053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymptomatic anti-HCV seropositive subjects include patients with chronic active hepatitis and individuals with normal liver: can we distinguish them?
    Manzini P; Calvo PL; Abate ML; Cerchier A; Piantino P; Vallauri P; D'Antico S; Sympson B; Klarmann R; Schiffer M
    J Hepatol; 1994 Jul; 21(1):136-7. PubMed ID: 7525695
    [No Abstract]   [Full Text] [Related]  

  • 25. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV.
    Lin HH; Hsu HY; Chang MH; Wang JT; Chen PJ; Chen DS
    J Formos Med Assoc; 1992 Jul; 91(7):729-30. PubMed ID: 1360305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Seroprevalence of hepatitis C antiviral antibodies in blood donors in N'Djamena (Chad)].
    Massenet D; Djime O
    Bull Soc Pathol Exot; 1993; 86(4):235. PubMed ID: 7507370
    [No Abstract]   [Full Text] [Related]  

  • 27. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HCV related to HCV PCR and risk factors analysis in a blood donor population of central Brazil.
    Martins RM; Vanderborght BO; Rouzere CD; Santana CL; Santos CO; Mori DN; Ferreira RG; Yoshida CF
    Rev Inst Med Trop Sao Paulo; 1994; 36(6):501-6. PubMed ID: 7569623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood donor screening for hepatitis C.
    Dusheiko GM
    S Afr Med J; 1993 Mar; 83(3):217-8. PubMed ID: 8390101
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C--the virus as well as the antibody.
    Sweeting J
    Gastroenterology; 1991 Apr; 100(4):1144-5. PubMed ID: 1848197
    [No Abstract]   [Full Text] [Related]  

  • 32. On the positivity of the test for anti-HCV considerations in dialized patients.
    Avella F; Irlando A; Scancariello G; Iovino R
    Nephron; 1992; 61(3):341. PubMed ID: 1323785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reactivity of hepatitis C virus (HCV) antibody among blood donors in Hungary].
    Héjjas M; Medgyesi G; Hajnal A
    Orv Hetil; 1992 Jul; 133 Suppl 1():21-4. PubMed ID: 1321394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The verification of the results of screening antibodies to hepatitis C virus in blood donors].
    Zhiburt EB; Asadi AKh; Cherkasov EG; Reĭzman PV
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):71-3. PubMed ID: 16279540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iatrogenic hepatitis C virus transmission via commercial plasma donation in Spain.
    Davis AR
    Pathology; 1998 Nov; 30(4):427. PubMed ID: 9839323
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis C virus antibody positive blood donors.
    Mutimer D; Shaw J; Harrison R; Ala F; Neuberger J; Elias E
    Gut; 1993; 34(2 Suppl):S54. PubMed ID: 7686116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of anti-hepatitis C virus antibody in healthy blood donors in China: enzyme immunoassay and recombinant immunoblot].
    Zhang YY; Yan XB; Li FH
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):695-8, 730-1. PubMed ID: 1667749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C infection in liver transplant patients.
    McCaughan GW; Pau A; Parsons C; McGuinness PH; Gallagher ND; Sheil AG
    Transplant Proc; 1992 Oct; 24(5):2256. PubMed ID: 1384207
    [No Abstract]   [Full Text] [Related]  

  • 40. [Practical approach to the discovery of a positive HCV serology in a blood donor].
    Elghouzzi MH; Giral P; Opolon P; Trepo C; Poupon R; Jullien AM
    Rev Fr Transfus Hemobiol; 1991 Jul; 34(4):315-42. PubMed ID: 1654911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.